AMIX insider transaction filings
Autonomix Medical, Inc. — 15 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-21. Screen AMIX transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 4 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Bisson Lori — Director | 1 | — | — | 1 |
| Hauser Bradley — CEO and President | 1 | — | — | 1 |
| KLEMP WALTER V — Director | 1 | — | — | 1 |
| Smith Trent N. — CFO | 1 | — | — | 1 |
Recent Form 4 filings — Autonomix Medical, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-21 | 4 | Smith Trent N. — CFO | Grant/award (A): 15,000 | EDGAR |
| 2026-09-08 | 4 | Bisson Lori — Director | Grant/award (A): 13,000 | EDGAR |
| 2026-09-08 | 4 | KLEMP WALTER V — Director | Grant/award (A): 13,000 | EDGAR |
| 2026-09-08 | 4 | Hauser Bradley — CEO and President | Grant/award (A): 27,000 | EDGAR |
| 2025-08-13 | 4 | Hauser Bradley — CEO and President | Disposition to issuer (D): 45,000 (derivative) | EDGAR |
| 2025-08-13 | 4 | Capelli Christopher — Director | Disposition to issuer (D): 3,750 (derivative) | EDGAR |
| 2025-08-13 | 4 | KLEMP WALTER V — Director | Disposition to issuer (D): 8,773 (derivative) | EDGAR |
| 2025-08-13 | 4 | Bisson Lori — Director | Disposition to issuer (D): 18,862 (derivative) · Disposition to issuer (D): 46,680 (derivative) | EDGAR |
| 2025-08-13 | 4 | Smith Trent N. — CFO | Disposition to issuer (D): 11,405 (derivative) · Disposition to issuer (D): 21,250 (derivative) | EDGAR |
| 2024-07-26 | 4 | Robins David Andrew — Director | Purchase (P): 103,990 (derivative) @ $0.00 | EDGAR |
| 2024-06-24 | 4 | Bisson Lori — Director | Grant/award (A): 377,221 (derivative) | EDGAR |
| 2024-06-24 | 4 | KLEMP WALTER V — Director | Grant/award (A): 175,452 (derivative) | EDGAR |
| 2024-06-24 | 4 | Smith Trent N. — CFO | Grant/award (A): 228,087 (derivative) | EDGAR |
| 2024-06-20 | 4 | Hauser Bradley — CEO and President | Grant/award (A): 900,000 (derivative) | EDGAR |
| 2024-06-20 | 4 | BioStar Ventures III, L.P. — 10% owner | Purchase (P): 1,088,000 (derivative) @ $0.03 | EDGAR |
Recent 8-K events — Autonomix Medical, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-26 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-28 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-07-15 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-10 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-24 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-16 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-01-09 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-03 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AMIX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →